Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 31, Issue 6, Pages 848-860
Publisher
Wiley
Online
2016-05-02
DOI
10.1002/mds.26635
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal Fluid α-Synuclein Does Not Discriminate Between Dementia Disorders
- (2017) Petra E. Spies et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
- (2017) Fransje E. Reesink et al. JOURNAL OF ALZHEIMERS DISEASE
- A comprehensive map and functional annotation of the normal human cerebrospinal fluid proteome
- (2015) Yang Zhang et al. Journal of Proteomics
- SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
- (2014) Ann Brinkmalm et al. Molecular Neurodegeneration
- Differential expression of synaptic proteins in unilateral 6-OHDA lesioned rat model-A comparative proteomics approach
- (2014) Yan Xiong et al. PROTEOMICS
- Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis
- (2014) Virginie Licker et al. PROTEOMICS
- Emerging Candidate Biomarkers for Parkinson’s Disease: a Review
- (2014) Enrico Saracch Aging and Disease
- Plasma apolipoprotein A1 as a biomarker for Parkinson disease
- (2013) Judy K. Qiang et al. ANNALS OF NEUROLOGY
- G51D α-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome
- (2013) Suzanne Lesage et al. ANNALS OF NEUROLOGY
- Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
- (2013) Silke Appel-Cresswell et al. MOVEMENT DISORDERS
- Cerebrospinal fluid biomarkers in Parkinson disease
- (2013) Lucilla Parnetti et al. Nature Reviews Neurology
- Genetics of Parkinson's Disease
- (2013) C. Klein et al. Cold Spring Harbor Perspectives in Medicine
- Can we clinically diagnose dementia with Lewy bodies yet?
- (2013) Yue Huang et al. Translational Neurodegeneration
- Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
- (2012) Marta del Campo et al. Biomarkers in Medicine
- iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia
- (2012) Stefan Lehnert et al. EXPERIMENTAL NEUROLOGY
- Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease
- (2012) Tiziana Alberio et al. IUBMB LIFE
- Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease
- (2012) Virginie Licker et al. Journal of Proteomics
- Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy
- (2012) Noriko Ishigami et al. MOVEMENT DISORDERS
- Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects
- (2012) Chera L Maarouf et al. NEUROLOGICAL RESEARCH
- α-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers
- (2012) Ana Gorostidi et al. PLoS One
- Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson’s Disease Dementia
- (2012) Sarah Jesse et al. PLoS One
- A comparative analysis of computational approaches to relative protein quantification using peptide peak intensities in label-free LC-MS proteomics experiments
- (2012) Melissa M. Matzke et al. PROTEOMICS
- Phosphorylated -Synuclein in Parkinson's Disease
- (2012) Y. Wang et al. Science Translational Medicine
- Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease
- (2012) Tiziana Alberio et al. Scientific Reports
- Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Clifford R. Jack et al. Alzheimers & Dementia
- Genome-wide Association Study Identifies Genetic Variation in Neurocan as a Susceptibility Factor for Bipolar Disorder
- (2011) Sven Cichon et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Quantitative proteomic analysis of serum proteins in patients with Parkinson’s disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry
- (2011) Xiaping Zhang et al. ANALYST
- Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease
- (2011) Ivana Devic et al. BRAIN
- The Proteome of the Locus Ceruleus in Parkinson's Disease: Relevance to Pathogenesis
- (2011) Karin D. van Dijk et al. BRAIN PATHOLOGY
- Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach
- (2011) Han-Min Chen et al. CLINICAL BIOCHEMISTRY
- Structural basis for cell surface patterning through NetrinG-NGL interactions
- (2011) Elena Seiradake et al. EMBO JOURNAL
- Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Combined with Magnetic Beads for Detecting Serum Protein Biomarkers in Parkinson’s Disease
- (2011) Yao-Hua Li et al. EUROPEAN NEUROLOGY
- Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
- (2011) Penelope G. Foulds et al. FASEB JOURNAL
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson’s disease
- (2010) Pablo Garcia-Reitböck et al. BRAIN
- Abnormal expression of netrin-G2 in temporal lobe epilepsy neurons in humans and a rat model
- (2010) Yumin Pan et al. EXPERIMENTAL NEUROLOGY
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- Proteome analysis of the sera from Chinese Parkinson's disease patients
- (2010) Xin Zhao et al. NEUROSCIENCE LETTERS
- Proteomic profiling of cerebrospinal fluid in parkinsonian disorders
- (2010) Radu Constantinescu et al. PARKINSONISM & RELATED DISORDERS
- Identification of Glutathione S -Transferase Pi as a Protein Involved in Parkinson Disease Progression
- (2009) Min Shi et al. AMERICAN JOURNAL OF PATHOLOGY
- Abnormal serum concentrations of proteins in Parkinson’s disease
- (2009) Ira L. Goldknopf et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases
- (2009) Guo Nan Yin et al. BRAIN RESEARCH
- Proteomic analysis of the cerebrospinal fluid of Parkinson's disease patients
- (2009) Jiguang Guo et al. CELL RESEARCH
- Neurochemical Approaches in the Laboratory Diagnosis of Parkinson and Parkinson Dementia Syndromes: A Review
- (2009) Sarah Jesse et al. CNS Neuroscience & Therapeutics
- Characterization of PEDF: A multi-functional serpin family protein
- (2009) S. Filleur et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- α-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood
- (2009) Gregory B. Pott et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Fluorescence two-dimensional difference gel electrophoresis for biomaterial applications
- (2009) L. E. McNamara et al. Journal of the Royal Society Interface
- Neurochemical biomarkers in the differential diagnosis of movement disorders
- (2009) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Biological fluid biomarkers in neurodegenerative parkinsonism
- (2009) Michael Eller et al. Nature Reviews Neurology
- The crosstalk of hyaluronan-based extracellular matrix and synapses
- (2009) Renato Frischknecht et al. Neuron Glia Biology
- Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease
- (2009) Torsten Falk et al. NEUROSCIENCE LETTERS
- A Swedish family with de novo α-synuclein A53T mutation: Evidence for early cortical dysfunction
- (2009) Andreas Puschmann et al. PARKINSONISM & RELATED DISORDERS
- Metabolomic Profiling in LRRK2-Related Parkinson's Disease
- (2009) Krisztina K. Johansen et al. PLoS One
- Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics
- (2009) Ling Lin et al. TRENDS IN NEUROSCIENCES
- Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: A proteomic approach
- (2008) Ashima Sinha et al. CLINICA CHIMICA ACTA
- Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
- (2008) Brit Mollenhauer et al. EXPERIMENTAL NEUROLOGY
- Polymers and inflammation: disease mechanisms of the serpinopathies
- (2008) Bibek Gooptu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mortalin: A Protein Associated With Progression of Parkinson Disease?
- (2008) Min Shi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization
- (2008) Masayuki Yamasaki et al. NATURE
- Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease
- (2008) Jung Mi Choi et al. NEUROGENETICS
- Association of polymorphisms in the haplotype block spanning the alternatively spliced exons of the NTNG1 gene at 1p13.3 with schizophrenia in Japanese populations
- (2008) T. Ohtsuki et al. NEUROSCIENCE LETTERS
- Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
- (2008) Annika Öhrfelt et al. NEUROSCIENCE LETTERS
- Proteome analysis of human substantia nigra in Parkinson's disease
- (2008) Cornelius J Werner et al. Proteome Science
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started